References
- Bahn RS. Graves ophthalmopathy. N Engl J Med 2010;362:726–738
- Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ophthalmopathy. Thyroid 2002;12:855–860
- Wiersinga WM, Smit T, van der Gaag R, Koornneef L. Temporal relationship between onset of Graves’ ophthalmopathy and onset of thyroidal Graves’ disease. J Endocrinol Invest 1988;11:615–619
- Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995;42:45–50
- Robinson D, Wilcsek G, Sacks R. Orbit and orbital apex. Otolaryngol Clin North Am 2011;44:903–922
- Kazim M, Trokel SL, Acaroglu G, Elliott A. Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol 2000;84:600--605
- Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of Graves ophthalmopathy. Med Clin North Am 2012;96:311–328
- Nugent RA, Belkin RI, Neigel JM, Rootman J, et al. Graves orbitopathy: correlation of CT and clinical findings. Radiology 1990;177:675–682
- Chan LL, Tan HE, Fook-Chond S, Teo TH, et al. Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. Am J Neuroradiol 2009;30:597–602
- Lee HB, Rodgers IR, Woog JJ. Evaluation and management of Graves’ orbitopathy. Otolaryngol Clin North Am 2006;39:923--942